BackNKGen Biotech- Warrants (01/09/2028) Overview

NKGen Biotech- Warrants (01/09/2028) Total Current Liabilities

Track NKGen Biotech- Warrants (01/09/2028)'s total current liabilities ($44M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$43.89M
↑ 17.09% YoYΔ $6.41M vs prior year quarter

Peer trimmed avg / median

Loading

NKGen Biotech- Warrants (01/09/2028) Total Current Liabilities History

Loading

NKGen Biotech- Warrants (01/09/2028) vs. peers: Total Current Liabilities Comparison

Loading

NKGen Biotech- Warrants (01/09/2028) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NKGen Biotech- Warrants (01/09/2028) (NKGNW) FAQ

NKGen Biotech- Warrants (01/09/2028) (NKGNW) currently reports a total current liabilities of $44M as of March 2025. That compares with $37M in the prior-year period — up 17.1% year over year. Use the charts on this page to explore NKGen Biotech- Warrants (01/09/2028)'s total current liabilities history and peer comparisons.

NKGen Biotech- Warrants (01/09/2028)'s total current liabilities increased from $37M to $44M — a 17.1% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NKGen Biotech- Warrants (01/09/2028) reported $44M in total current liabilities as of March 2025. That compares with $37M in the prior-year period — up 17.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $44M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NKGen Biotech- Warrants (01/09/2028), and consider following NKGNW for alerts when major investors trade the stock.